Jobs / United States / Eikon Therapeutics INC
Senior Scientist, Computational Biology
Eikon Therapeutics INC · 🇺🇸 Millbrae, CA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Eikon Therapeutics INC
The US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Eikon Therapeutics INC →
About the role
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets. Position We seek a Senior Scientist in Computational Biology to drive diverse early drug discovery efforts across Eikon’s target portfolio. In this key role, the successful applicant will use their rigorous analytical skills in close collaboration with diverse discovery scientists to conceive and evaluate complex, progress-enabling experiments across our target portfolio. This person will also help shape how Eikon evaluates and adopts novel experimental systems and will partner with colleagues developing quantitative models to ensure that emerging computational methods remain grounded in sound biological reasoning. About You For this role, we are seeiking an experienced, rigorous, and results-driven computational scientist with a strong track record driving high impact contributions to advance early research drug discovery programs. You are an enthusiastic and generous collaborator who is skilled in both traditional and emergent drug discovery technologies and is comfortable working in a fast-paced, cross-functional environment uniting diverse disciplines and subject matter experts . This role will require someone who is curious, detail-oriented, and a strategic thinker who can draw on deep technical and biological knowledge to synthesize data from diverse internal and external sources to resolve nuanced scientific questions. You bring both scientific depth and methodological creativity to bear on emerging experimental systems and works closely with quantitative modeling colleagues to ground new computational approaches in strong biological reasoning. What You’ll Do • Drive the development and adoption of novel experimental systems and techniques relevant to Eikon’s target portfolio, collaborating closely with experimental and computational teams across programs • Develop and apply analytical approaches, statistical methods, and proof-of-concept tools to support new experimental strategies • Analyze multimodal data to evaluate experimental systems, identify enabling insights, and define the limits of interpretation for biological applications • Apply statistical, biological, and experimental expertise to evaluate complex experiments. Distill information from diverse sources to reach relevant and testable biological conclusions Qualifications • Postdoc Fellowship plus 2 years of relevant experience or PhD in bioinformatics, computational biology, or a quantitative field with deep expertise in statistics or method development, plus 5 years of relevant industry experience. • Hands-on experience developing and applying methods for high-dimensional, multi-modal datasets, including experience designing, evaluating, and integrating high-throughput experiments. Ability to independently define analytical approaches for novel technologies, develop effective solutions, and validate results with minimal oversight. • Proven experience analyzing complex genomics datasets across one or more technical modalities, such as bulk, single-cell, or spatial transcriptomics, pooled or arrayed CRISPR screens, MAVEs or other multiplexed reporter assays, high content imaging data, Perturb-seq, or other relevant technologies • Experience working with large consortia and public datasets such as UK Biobank, TCGA, GT